<?xml version="1.0" encoding="UTF-8"?>
<ref id="B174-molecules-26-00495">
 <label>174.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ma</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Bavadekar</surname>
    <given-names>S.A.</given-names>
   </name>
   <name>
    <surname>Davis</surname>
    <given-names>Y.M.</given-names>
   </name>
   <name>
    <surname>Lalchandani</surname>
    <given-names>S.G.</given-names>
   </name>
   <name>
    <surname>Nagmani</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Schaneberg</surname>
    <given-names>B.T.</given-names>
   </name>
   <name>
    <surname>Feller</surname>
    <given-names>D.R.</given-names>
   </name>
  </person-group>
  <article-title>Pharmacological effects of ephedrine alkaloids on human α1-and α2-adrenergic receptor subtypes</article-title>
  <source>J. Pharmacol. Exp. Ther.</source>
  <year>2007</year>
  <volume>322</volume>
  <fpage>214</fpage>
  <lpage>221</lpage>
  <pub-id pub-id-type="doi">10.1124/jpet.107.120709</pub-id>
  <pub-id pub-id-type="pmid">17405867</pub-id>
 </element-citation>
</ref>
